GO
Loading...

Medicine

More

  • FDA approves new type of heart failure drug from Amgen Wednesday, 15 Apr 2015 | 4:53 PM ET

    TRENTON, N.J.— Patients with chronic heart failure, a disabling, deadly disease that worsens as the heart gradually pumps less efficiently, are getting a much-needed new option with U.S. approval Wednesday of a novel drug from Amgen Inc.. Meanwhile, the Food and Drug Administration is reviewing another heart failure pill, from Novartis AG, and could approve it this...

  • Aduro surges on IPO   Wednesday, 15 Apr 2015 | 11:24 AM ET
    Aduro surges on IPO

    Is it the golden age for cancer research Stephen Isaacs, Aduro Biotech CEO, discusses some of the advances in medicine of late.

  • WASHINGTON, April 14- AstraZeneca Plc's diabetes drug Onglyza and Takeda Pharmaceutical Co.' s rival product Nesina should carry information about the risk of heart failure, an advisory committee to the U.S. Food and Drug Administration said on Tuesday. The panel reviewed safety data on AstraZeneca's Onglyza and Takeda's Nesina. The studies were requested by...

  • Curing eye disease, and maybe color blindness   Tuesday, 14 Apr 2015 | 5:43 PM ET
    Curing eye disease, and maybe color blindness

    Avalanche Biotechnologies founder and CEO Thomas Chalberg, discusses treatments for wet macular degeneration, and a potential treatment for color blindness.

  • April 14- An advisory panel to the U.S. Food and Drug Administration voted 13-3 that Takeda Pharmaceutical's diabetes drug Nesina should contain information about a potential increased risk of heart failure. The panel voted 16-0 that the drug has an acceptable overall cardiovascular safety profile, with no significant increased risk of major heart events...

  • A preliminary FDA review of Nesina, or alogliptin, showed a numerical increase in heart failure hospitalizations but not a statistically significant increase. Even so, some analysts expect the FDA to treat all drugs in the class the same way. "We believe the FDA will likely view the risk as likely to be a class effect and apply changes to all approved drugs in the...

  • WASHINGTON, April 14- AstraZeneca Plc's diabetes drug Onglyza should include new safety information about the risk of heart failure, a U.S. Food and Drug Administration advisory panel concluded on Tuesday. The FDA is not obliged to follow the advice of its advisory panels but typically does so. A preliminary FDA review of the drug published on Friday noted an...

  • WASHINGTON, April 14- AstraZeneca Plc's diabetes drug Onglyza should include new safety information about the risk of heart failure, an advisory panel to the U.S. Food and Drug Administration concluded on Tuesday. The panel voted overwhelmingly that the drug's label should be changed to add information about an increased heart failure risk, but did not...

  • CHICAGO, April 13- A flock of 200,000 hens in Wisconsin is the first commercial U.S. chicken operation to become infected with a lethal strain of bird flu, the U.S. Department of Agriculture said, widening the impact of a virus that has killed hundreds of thousands of turkeys this year. The chickens were at an egg-laying facility in Jefferson County, Wisconsin,...

  • CHICAGO, April 13- The U.S. Department of Agriculture on Monday confirmed the first case of a lethal strain of bird flu in a commercial chicken flock, widening the impact of a virus that has already killed hundreds of thousands of turkeys this year. The H5N2 flu strain infected a commercial flock of 200,000 chickens in Jefferson County, Wisconsin, between Madison...

  • NEW YORK, April 12- Medical researchers call it the "Angelina Effect," the surge in demand for genetic testing attributable to movie star Angelina Jolie's public crusade for more aggressive detection of hereditary breast and ovarian cancer. But there's a catch: Major insurance companies including Aetna, Anthem and Cigna are declining to pay for the latest...

  • FDA PANEL: EVIDENCE DOES NOT SUPPORT CLAIM THAT SWEDISH MATCH'S SNUS PRODUCTS DO NOT POSE A RISK OF GUM DISEASE TO INDIVIDUAL USERS OF SNUS.

  • Johnson has made her investments through Impresa Management LLC, whose key shareholders include trusts for her and two siblings, Edward C. Johnson IV and Elizabeth Johnson, according to recent disclosures with the U.S. Securities and Exchange Commission. One of its biggest holdings at the end of last year was a $353 million stake in Chinese Internet commerce...

  • CHICAGO, April 8- A U.S. outbreak of a deadly strain of bird flu accelerated on Wednesday with the infection of a sixth turkey flock in Minnesota, the nation's top turkey-producing state, in less than a week. The infected flock of 310,000 turkeys was the ninth case of the H5N2 flu in Minnesota in just over a month and the biggest flock yet to be confirmed with the...

  • April 6- Ocular Therapeutix Inc said its lead eye drug failed to meet one of the main goals in a second late-stage study. Both endpoints needed to be met for the trial to be considered successful, Ocular Therapeutix said. The company said it plans to meet the U.S. Food and Drug Administration to discuss the trial results.

  • April 6- Ocular Therapeutix Inc says its lead eye drug failed to meet one of the main goals in a second late-stage study. Both endpoints needed to be met for the trial to be considered successful, Ocular Therapeutix said. Ocular Therapeutix said in March that the drug reduced pain and inflammation in patients in a first late-stage trial.

  • CDC warns of new outbreak   Thursday, 2 Apr 2015 | 1:00 PM ET
    CDC warns of new outbreak

    CNBC's Meg Tirrell reports the CDC is warning about a drug-resistant illness outbreak called Shigella.

  • FRANKFURT, April 1- Roche, the world's largest cancer drugmaker, is ready to collaborate with rivals to find new combination therapies for multi-pronged treatments, its chief executive said. Roche is vying with rivals such as Bristol-Myers Squibb, Merck& Co and AstraZeneca to develop such immuno-oncology therapies that harness the power of the body's immune...

  • E-cigarettes: The new gateway drug for teens? Tuesday, 31 Mar 2015 | 11:43 AM ET

    E-cigarettes may have been marketed as a healthier option to cigarettes, yet, a new report shows that 1 in 5 U.K. teenagers have tried them.

  • An outbreak of Ebola killed close to 10,000 people across West Africa over the last year, with Liberia, Guinea and Sierra Leone being the worst affected. Private company Mapp Biopharmaceutical and Tekmira Pharmaceuticals Corp have shown that their Ebola drugs could cure non-human primates. The other companies that are currently testing potential...